March 26, 2025

What’s Brewing at Work May Raise Heart Risks

Research identifies high levels of LDL-raising compounds in workplace coffee machine brews, potentially increasing cardiovascular risk for regular consumers.

Conexiant

March 24, 2025

Cannabis Use: Multicenter Study Links to Increased MI, Stroke Risks

Cannabis use associated with over sixfold higher risk of myocardial infarction in otherwise healthy adults, according to new multicenter study.

Conexiant

March 19, 2025

Study: Sex Differences in Physician Suicide

Researchers found that female physicians had a significantly higher suicide risk than female nonphysicians.

Conexiant

March 19, 2025

Passive Heat Therapy Improves Heart Failure Mobility

A randomized trial found that heating the lower limbs increased exercise endurance in heart failure patients, with blood flow rising significantly after treatment.

Conexiant

March 18, 2025

Lipid Changes Post-Ivacaftor in Cystic Fibrosis

Cholesterol levels in cystic fibrosis patients were found to increase within 3 months of starting ivacaftor therapy, then returned to baseline by 18 months.

Conexiant

March 17, 2025

Statins Reduce HCC Risk in Liver Disease

New research shows statin therapy significantly lowers hepatocellular carcinoma and hepatic decompensation risk while improving fibrosis outcomes in chronic liver disease patients with elevated FIB-4 scores.

Conexiant

March 14, 2025

Maternal Health Trajectories: CVD Risks Start Before Pregnancy

Women with adverse pregnancy outcomes had higher BMI, BP, and glucose 10 years before pregnancy and persistently elevated risks up to 15 years postpartum, a new cohort study finds.

Conexiant

March 14, 2025

Reduced-Dose Anticoagulants Lower Bleeding, Study Finds

Findings indicate that while non-inferiority was not established, the reduced-dose regimen resulted in fewer bleeding complications without a marked increase in venous thromboembolism (VTE) recurrence.

Conexiant

March 14, 2025

No Increased Cardiovascular Risk with Nicotinamide Use: Study

Analysis of over 13,000 patients across two cohorts found that nicotinamide exposure was not associated with increased risk of major adverse cardiovascular events

Conexiant